Tilray, Inc.
(NASDAQ : TLRY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.54%202.831.3%$744.45m
GILDGilead Sciences, Inc.
-0.52%63.800.9%$380.33m
CELGCelgene Corporation
-0.37%95.331.3%$341.59m
BIIBBiogen Inc.
-0.78%231.371.3%$294.06m
ILMNIllumina, Inc.
-1.07%287.393.5%$288.71m
ALXNAlexion Pharmaceuticals, Inc.
1.54%116.612.0%$259.69m
VRTXVertex Pharmaceuticals Incorporated
-1.73%183.181.9%$253.39m
EXASExact Sciences Corporation
-1.22%117.7824.1%$241.06m
REGNRegeneron Pharmaceuticals, Inc.
-1.13%294.432.6%$210.25m
AAgilent Technologies, Inc.
-0.62%71.751.6%$199.58m
SRPTSarepta Therapeutics, Inc.
-8.63%92.7414.7%$160.37m
INCYIncyte Corporation
-1.12%85.112.5%$99.20m
BMRNBioMarin Pharmaceutical Inc.
-0.91%77.514.3%$96.52m
GHDXGenomic Health, Inc.
-0.55%73.951.8%$86.65m
SGENSeattle Genetics, Inc.
-2.50%77.976.5%$79.88m

Company Profile

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.